🟢 OUTLOOK THERAPEUTICS INC is trading 7% up today after FDA accepts BLA resubmission for ONS-5010

OUTLOOK THERAPEUTICS INC is trading at $1.68 (7% up) today after the FDA accepted the company’s resubmitted BLA for ONS-5010 for wet AMD.

• The FDA assigned a PDUFA goal date of July 29, 2025, providing a definitive regulatory timeline for the investigational ophthalmic formulation.
• The acceptance extends a sharp rally from the previous session, driven by renewed speculative interest and momentum following the regulatory milestone.